ClinConnect ClinConnect Logo
Search / Trial NCT00741494

Effectiveness of the Use of the PICSI Dish (Hyaluronan Microdot) in the Selection of Sperm for Intracytoplasmic Sperm Injection (ICSI)

Launched by BIOCOAT · Aug 25, 2008

Trial Information

Current as of April 24, 2025

Completed

Keywords

Infertility Icsi Hyaluronan Binding Sperm Sperm Selection Male Factor Hyaluronan Sperm Maturity Clinical Pregnancy Rates Hyaluronan Binding Assay Hba Picsi

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • IVF patients who require the ICSI procedure and whose care is being managed by the clinical and scientific staff of the participating groups, will be included in the study.
  • Exclusion Criteria:
  • * IVF patients who do not require the ICSI procedure will be excluded from the study. In addition the following groups of patients will also be excluded:
  • Patients using testicular sperm.
  • Patients using donor sperm.
  • Patients where the female partner is over 40 years of age
  • Patients who have an initial HBA score less than or equal to 2%
  • Patients who have a sperm count less than or equal to 10,000 motile sperm per ml.
  • Patients who produce less than 4 Metaphase II oocytes

Trial Officials

Kathryn Worrilow, Ph.D.

Study Director

Biocoat

About Biocoat

Biocoat is a leading innovator in the development of advanced biocompatible materials for medical applications, specializing in the creation of hydrophilic coatings that enhance the performance of medical devices. With a strong commitment to improving patient outcomes, Biocoat leverages cutting-edge technology and rigorous research to provide solutions that reduce friction, enhance lubricity, and promote patient safety. The company collaborates closely with clinical and regulatory partners to ensure that its products meet the highest standards of quality and efficacy, positioning itself as a trusted sponsor in the clinical trial landscape.

Locations

Seattle, Washington, United States

Laguna Hills, California, United States

San Ramon, California, United States

Atlanta, Georgia, United States

Atlanta, Georgia, United States

Chicago, Illinois, United States

Syracuse, New York, United States

Abington, Pennsylvania, United States

Providence, Rhode Island, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials